Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study. Design and practical implications of an intervention for comorbid pain and depression

Kurt Kroenke, Matthew Bair, Teresa Damush, Shawn Hoke, Gloria Nicholas, Carol Kempf, Monica Huffman, Jingwei Wu, Jason Sutherland

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Objective: Depression and pain are common comorbid conditions that have reciprocal adverse effects on disability and treatment outcomes. The objective of this article is to describe a study that tests the effectiveness of a stepped-care approach using a combined medication-behavioral intervention. Method: Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) is an NIMH-sponsored randomized clinical trial nested within a prospective cohort study. A total of 250 patients with clinically significant depression (PHQ-9 scores ≥10) and musculoskeletal pain of the lower back or legs (hip or knee) and 250 nondepressed patients with similar pain are enrolled, with baseline and serial follow-up assessments to be conducted over 12 months. The depressed patients are randomized to either a stepped-care intervention group or a usual-care control group. Stepped-care patients receive 12 weeks of optimized antidepressant management (Step 1) followed by six sessions of a pain self-management (PSM) program over the next 12 weeks (Step 2), all delivered by a nurse care manager who is supervised by a physician specialist. Approximately two thirds of the care manager contacts are by telephone. Results: The target sample of 500 subjects has been successfully enrolled, and randomization of the depressed patients has resulted in balanced groups of patients with moderately severe pain and depression. Mean SCL-20 depression severity in the clinical trial group is 1.9, with most meeting DSM-IV criteria for major depression (76.3%) and the rest having dysthymia only (18.4%) or minor depression (5.3%). Pain is about equally distributed between lower back (53%) and hip or knee (47%). A rational algorithmic approach to antidepressant selection and dosing, as well as an overview of the PSM program, is provided. Conclusions: When completed, SCAMP will test whether optimized antidepressant management improves outcomes in patients with comorbid depression and pain and whether PSM produces additional benefits. The findings will be important for both primary care and mental health clinicians confronted by the prevalent depression-pain dyad.

Original languageEnglish
Pages (from-to)506-517
Number of pages12
JournalGeneral Hospital Psychiatry
Volume29
Issue number6
DOIs
StatePublished - Nov 2007

Fingerprint

Musculoskeletal Pain
Mood Disorders
Depression
Pain
Pain Management
Self Care
Antidepressive Agents
Hip
Knee
National Institute of Mental Health (U.S.)
Random Allocation
Telephone
Diagnostic and Statistical Manual of Mental Disorders
Primary Health Care
Leg
Patient Care
Mental Health
Cohort Studies
Randomized Controlled Trials
Nurses

Keywords

  • Antidepressants
  • Depression
  • Pain
  • Pain self-management
  • Primary care

ASJC Scopus subject areas

  • Emergency Medicine
  • Medicine(all)
  • Psychiatry and Mental health

Cite this

Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study. Design and practical implications of an intervention for comorbid pain and depression. / Kroenke, Kurt; Bair, Matthew; Damush, Teresa; Hoke, Shawn; Nicholas, Gloria; Kempf, Carol; Huffman, Monica; Wu, Jingwei; Sutherland, Jason.

In: General Hospital Psychiatry, Vol. 29, No. 6, 11.2007, p. 506-517.

Research output: Contribution to journalArticle

@article{dc8e79735ad2479eb254a6c138828cf3,
title = "Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study. Design and practical implications of an intervention for comorbid pain and depression",
abstract = "Objective: Depression and pain are common comorbid conditions that have reciprocal adverse effects on disability and treatment outcomes. The objective of this article is to describe a study that tests the effectiveness of a stepped-care approach using a combined medication-behavioral intervention. Method: Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) is an NIMH-sponsored randomized clinical trial nested within a prospective cohort study. A total of 250 patients with clinically significant depression (PHQ-9 scores ≥10) and musculoskeletal pain of the lower back or legs (hip or knee) and 250 nondepressed patients with similar pain are enrolled, with baseline and serial follow-up assessments to be conducted over 12 months. The depressed patients are randomized to either a stepped-care intervention group or a usual-care control group. Stepped-care patients receive 12 weeks of optimized antidepressant management (Step 1) followed by six sessions of a pain self-management (PSM) program over the next 12 weeks (Step 2), all delivered by a nurse care manager who is supervised by a physician specialist. Approximately two thirds of the care manager contacts are by telephone. Results: The target sample of 500 subjects has been successfully enrolled, and randomization of the depressed patients has resulted in balanced groups of patients with moderately severe pain and depression. Mean SCL-20 depression severity in the clinical trial group is 1.9, with most meeting DSM-IV criteria for major depression (76.3{\%}) and the rest having dysthymia only (18.4{\%}) or minor depression (5.3{\%}). Pain is about equally distributed between lower back (53{\%}) and hip or knee (47{\%}). A rational algorithmic approach to antidepressant selection and dosing, as well as an overview of the PSM program, is provided. Conclusions: When completed, SCAMP will test whether optimized antidepressant management improves outcomes in patients with comorbid depression and pain and whether PSM produces additional benefits. The findings will be important for both primary care and mental health clinicians confronted by the prevalent depression-pain dyad.",
keywords = "Antidepressants, Depression, Pain, Pain self-management, Primary care",
author = "Kurt Kroenke and Matthew Bair and Teresa Damush and Shawn Hoke and Gloria Nicholas and Carol Kempf and Monica Huffman and Jingwei Wu and Jason Sutherland",
year = "2007",
month = "11",
doi = "10.1016/j.genhosppsych.2007.08.005",
language = "English",
volume = "29",
pages = "506--517",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study. Design and practical implications of an intervention for comorbid pain and depression

AU - Kroenke, Kurt

AU - Bair, Matthew

AU - Damush, Teresa

AU - Hoke, Shawn

AU - Nicholas, Gloria

AU - Kempf, Carol

AU - Huffman, Monica

AU - Wu, Jingwei

AU - Sutherland, Jason

PY - 2007/11

Y1 - 2007/11

N2 - Objective: Depression and pain are common comorbid conditions that have reciprocal adverse effects on disability and treatment outcomes. The objective of this article is to describe a study that tests the effectiveness of a stepped-care approach using a combined medication-behavioral intervention. Method: Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) is an NIMH-sponsored randomized clinical trial nested within a prospective cohort study. A total of 250 patients with clinically significant depression (PHQ-9 scores ≥10) and musculoskeletal pain of the lower back or legs (hip or knee) and 250 nondepressed patients with similar pain are enrolled, with baseline and serial follow-up assessments to be conducted over 12 months. The depressed patients are randomized to either a stepped-care intervention group or a usual-care control group. Stepped-care patients receive 12 weeks of optimized antidepressant management (Step 1) followed by six sessions of a pain self-management (PSM) program over the next 12 weeks (Step 2), all delivered by a nurse care manager who is supervised by a physician specialist. Approximately two thirds of the care manager contacts are by telephone. Results: The target sample of 500 subjects has been successfully enrolled, and randomization of the depressed patients has resulted in balanced groups of patients with moderately severe pain and depression. Mean SCL-20 depression severity in the clinical trial group is 1.9, with most meeting DSM-IV criteria for major depression (76.3%) and the rest having dysthymia only (18.4%) or minor depression (5.3%). Pain is about equally distributed between lower back (53%) and hip or knee (47%). A rational algorithmic approach to antidepressant selection and dosing, as well as an overview of the PSM program, is provided. Conclusions: When completed, SCAMP will test whether optimized antidepressant management improves outcomes in patients with comorbid depression and pain and whether PSM produces additional benefits. The findings will be important for both primary care and mental health clinicians confronted by the prevalent depression-pain dyad.

AB - Objective: Depression and pain are common comorbid conditions that have reciprocal adverse effects on disability and treatment outcomes. The objective of this article is to describe a study that tests the effectiveness of a stepped-care approach using a combined medication-behavioral intervention. Method: Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) is an NIMH-sponsored randomized clinical trial nested within a prospective cohort study. A total of 250 patients with clinically significant depression (PHQ-9 scores ≥10) and musculoskeletal pain of the lower back or legs (hip or knee) and 250 nondepressed patients with similar pain are enrolled, with baseline and serial follow-up assessments to be conducted over 12 months. The depressed patients are randomized to either a stepped-care intervention group or a usual-care control group. Stepped-care patients receive 12 weeks of optimized antidepressant management (Step 1) followed by six sessions of a pain self-management (PSM) program over the next 12 weeks (Step 2), all delivered by a nurse care manager who is supervised by a physician specialist. Approximately two thirds of the care manager contacts are by telephone. Results: The target sample of 500 subjects has been successfully enrolled, and randomization of the depressed patients has resulted in balanced groups of patients with moderately severe pain and depression. Mean SCL-20 depression severity in the clinical trial group is 1.9, with most meeting DSM-IV criteria for major depression (76.3%) and the rest having dysthymia only (18.4%) or minor depression (5.3%). Pain is about equally distributed between lower back (53%) and hip or knee (47%). A rational algorithmic approach to antidepressant selection and dosing, as well as an overview of the PSM program, is provided. Conclusions: When completed, SCAMP will test whether optimized antidepressant management improves outcomes in patients with comorbid depression and pain and whether PSM produces additional benefits. The findings will be important for both primary care and mental health clinicians confronted by the prevalent depression-pain dyad.

KW - Antidepressants

KW - Depression

KW - Pain

KW - Pain self-management

KW - Primary care

UR - http://www.scopus.com/inward/record.url?scp=36048953884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048953884&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2007.08.005

DO - 10.1016/j.genhosppsych.2007.08.005

M3 - Article

VL - 29

SP - 506

EP - 517

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

IS - 6

ER -